T1	Participants 72 97	neuropathic pain patients
T2	Participants 363 391	60 patients with neuropathic
T3	Participants 836 867	55 patients completed the study
T4	Participants 1005 1058	groups regarding pain intensity and escape medication
T5	Participants 1137 1179	venlafaxine groups compared to the placebo
T6	Participants 1229 1292	groups regarding the detection thresholds (electrical and heat)
